| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/07/2013 | US20130295050 Anti-igf-i receptor antibodies, dnas, vectors, host cells and genetic constructs |
| 11/07/2013 | US20130295049 Linked dibenzimidazole antivirals |
| 11/07/2013 | US20130295048 Crystalline form of a pyridyl-piperazinyl hepatitis c virus inhibitor |
| 11/07/2013 | US20130295047 Clip modulation for the treatment of mucosal diseases |
| 11/07/2013 | US20130295045 Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 11/07/2013 | US20130295041 Novel Composition |
| 11/07/2013 | US20130295037 In situ bonds |
| 11/07/2013 | US20130295027 Oral care composition |
| 11/07/2013 | US20130295026 Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin |
| 11/07/2013 | US20130295025 Use of beta-adrenergic inverse agonists for smoking cessation |
| 11/07/2013 | US20130295022 Moisturizing Foam Containing Lanolin |
| 11/07/2013 | US20130295012 Shear controlled release for stenotic lesions and thrombolytic therapies |
| 11/07/2013 | US20130295009 Method of treating inflammation |
| 11/07/2013 | US20130291860 Method For Treating Cystic Fibrosis with Inhaled Denufosol |
| 11/07/2013 | DE102012207471A1 Mineralische Verbindung und deren Modifikationen zur Anwendung bei chronisch-entzündlichen Darmerkrankungen Mineral compound and its modifications for use in chronic inflammatory bowel disease |
| 11/07/2013 | DE102012104007A1 Polysubstituierte arene und deren synthese Polysubstituted arenes and their synthesis |
| 11/07/2013 | CA2854229A1 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 11/06/2013 | EP2660335A2 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorgamisms from clinical specimens for diagnosis |
| 11/06/2013 | EP2660322A2 Modified iRNA agents |
| 11/06/2013 | EP2660245A1 Physiologically active bis-dialkylamides of phosphoryl-substituted 1,4-dicarboxylic acids and method for producing same |
| 11/06/2013 | EP2660242A1 Crystalline form of ertapenem sodium and preparation method therefor |
| 11/06/2013 | EP2660241A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
| 11/06/2013 | EP2660240A1 Benzopyrone estrogen receptor regulator |
| 11/06/2013 | EP2660238A1 Compounds for the prevention and treatment of cardiovascular disease |
| 11/06/2013 | EP2659933A1 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc. |
| 11/06/2013 | EP2659910A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells |
| 11/06/2013 | EP2659909A2 Photodynamic therapy for the treatment of acne |
| 11/06/2013 | EP2659895A1 Pharmaceutical composition including hyaluronic acid and a zinc compound and corresponding bar on a stick and preparation method |
| 11/06/2013 | EP2659894A1 Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| 11/06/2013 | EP2659893A2 T cell regulation |
| 11/06/2013 | EP2659892A1 Concomitant drug for improving cognitive function |
| 11/06/2013 | EP2659891A1 Drug with activity against the herpes virus family |
| 11/06/2013 | EP2659890A1 Methods and compositions for the treatment of fibrosis |
| 11/06/2013 | EP2659889A1 Antipyretic/analgesic composition |
| 11/06/2013 | EP2659888A1 Use of aminolevulinic acid and derivatives thereof |
| 11/06/2013 | EP2659887A1 Use of A-ring aromatic acetyl minocycline and pharmaceutical preparations derived from same for treatment and prevention of inflammation, autoimmune disorders and rejection of transplants |
| 11/06/2013 | EP2659886A1 Patch |
| 11/06/2013 | EP2659885A1 Hepatitis C Antiviral Compositions and Methods |
| 11/06/2013 | EP2659884A2 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 11/06/2013 | EP2659881A1 A delayed release drug formulation |
| 11/06/2013 | EP2659782A1 Methods of improving mental or health conditions |
| 11/06/2013 | EP2659773A1 Improved tissue maintenance |
| 11/06/2013 | EP2658982A1 Small molecule conjugates for intracellular delivery of biologically active compounds |
| 11/06/2013 | EP2658981A1 Small molecule conjugates for intracellular delivery of nucleic acids |
| 11/06/2013 | EP2658976A2 Nucleic acid molecules that target the rho1 small gtp-binding protein and confer resistance to coleopteran pests |
| 11/06/2013 | EP2658973A2 siRNA FOR INHIBITION OF Hif1alpha EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME |
| 11/06/2013 | EP2658972A2 Melanoma treatments |
| 11/06/2013 | EP2658876A1 Method for the preparation of sodium chondroitin sulphate |
| 11/06/2013 | EP2658863A1 Novel antibacterial compounds |
| 11/06/2013 | EP2658859A2 Macrocyclic hepatitis c serine protease inhibitors |
| 11/06/2013 | EP2658858A2 Phenanthridine macrocyclic hepatitis c serine protease inhibitors |
| 11/06/2013 | EP2658857A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections |
| 11/06/2013 | EP2658854A2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 11/06/2013 | EP2658852A2 Compositions and methods of using crystalline forms of wortmannin analogs |
| 11/06/2013 | EP2658851A1 Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 11/06/2013 | EP2658848A1 New biaryl amide derivatives |
| 11/06/2013 | EP2658847A1 2 - (2 - phenylethenyl) - 1, 3 -benzothiazine derivatives useful for the treatment of cancer |
| 11/06/2013 | EP2658846A2 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof |
| 11/06/2013 | EP2658844A1 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| 11/06/2013 | EP2658843A1 Method of preparing polymorphic pure form a of bazedoxifene acetate |
| 11/06/2013 | EP2658836A1 Method for extracting silk extract containing lutein |
| 11/06/2013 | EP2658580A1 Arginase inhibitors and methods of use thereof |
| 11/06/2013 | EP2658578A1 Cellular hydration compositions containing cyclodextrins |
| 11/06/2013 | EP2658577A2 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof |
| 11/06/2013 | EP2658576A1 Medicated patch for improved transdermal permeation of diclofenac diethylammonium |
| 11/06/2013 | EP2658560A1 A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms |
| 11/06/2013 | EP2658559A1 Fiber and probiotics for reducing intestinal symptoms related to stress |
| 11/06/2013 | EP2658558A1 Fiber and probiotics for reducing intestinal symptoms related to chronic stress |
| 11/06/2013 | EP2658557A1 Enhancement of placental stem cell potency using modulatory rna molecules |
| 11/06/2013 | EP2658555A1 Cosmetic composition |
| 11/06/2013 | EP2658554A1 Systems and methods for treatment of allergies and other indications |
| 11/06/2013 | EP2658553A1 Cox-2 inhibitors and related compounds, and systems and methods for delivery thereof |
| 11/06/2013 | EP2658552A1 Delivery of treatments transdermally for fungal infections and other indications |
| 11/06/2013 | EP2658551A1 Treatment of erectile dysfunction and other indications |
| 11/06/2013 | EP2658550A1 Agonists of toll like receptor for treating cardiovasuclar disease and obesity |
| 11/06/2013 | EP2658549A1 Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
| 11/06/2013 | EP2658548A1 Human milk oligosaccharides for modulating inflammation |
| 11/06/2013 | EP2658547A1 Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
| 11/06/2013 | EP2658546A1 Methods of using human milk oligosaccharides for improving airway respiratory health |
| 11/06/2013 | EP2658545A1 Treatment of pain associated with dislocation of basal endometrium |
| 11/06/2013 | EP2658544A2 Oxidosqualene cyclase as a protein target for anticancer therapeutics |
| 11/06/2013 | EP2658543A1 Therapeutic compounds and compositions |
| 11/06/2013 | EP2658542A2 Topical localized isoxazoline formulation |
| 11/06/2013 | EP2658541A1 Topical localized isoxazoline formulation comprising glycofurol |
| 11/06/2013 | EP2658540A1 Therapeutic use of dimiracetam to prevent the hand&foot syndrome caused by sorafenib |
| 11/06/2013 | EP2658539A2 Composition for prevention of nausea or vomiting |
| 11/06/2013 | EP2658538A2 Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables |
| 11/06/2013 | EP2658537A1 METHOD OF TREATING SKIN WITH microRNA MODULATORS |
| 11/06/2013 | EP2658536A1 Gemcabene and derivatives for treating pancreatitis |
| 11/06/2013 | EP2658535A1 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate |
| 11/06/2013 | EP2658534A1 Topical nitrone spin trap compositions for psoriasis |
| 11/06/2013 | EP2658533A2 Combination of components for the prevention and treatment of frailty |
| 11/06/2013 | EP2658530A2 Orally disintegrating tablet |
| 11/06/2013 | EP2658528A1 Granulates comprising eslicarbazepine acetate |
| 11/06/2013 | EP2658523A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease |
| 11/06/2013 | EP2658517A1 Improved powderous vitamin e formulations |
| 11/06/2013 | EP2658512A2 Use of 13-hydroxy-9,11-octadecadienoic acid for tanning human skin, for dyeing human hair and for treating polymorphous light dermatosis |
| 11/06/2013 | EP2658402A1 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
| 11/06/2013 | EP2658401A2 Human milk oligosaccharides to promote growth of beneficial bacteria |
| 11/06/2013 | EP2658400A2 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |